Trump Orders CDC to Narrow Childhood Vaccine Recommendations

President Donald Trump signed an executive order on May 29 directing federal health agencies to align their policies with a scientific assessment that recommends significantly reducing the number of vaccines recommended for all American children. The order represents a major escalation in the administration’s overhaul of federal vaccine policy, driven by Health and Human Services Secretary Robert F. Kennedy Jr., a longtime vaccine skeptic, and comes amid an ongoing legal battle that has already blocked the narrower schedule once before.

The Executive Order

The order, titled “Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries,” acknowledges a January 2026 HHS scientific assessment as a guiding resource for the federal government. It directs the Centers for Disease Control and Prevention (CDC) and its Advisory Committee on Immunization Practices (ACIP) to review the assessment and “take any appropriate steps” to update the childhood and adolescent vaccine schedule.

According to the White House, the order is designed to “provide maximum flexibility to parents and doctors” while ensuring that Americans retain their current access to vaccines, with all immunizations continuing to be covered without cost-sharing by private insurance, Medicaid, CHIP, and the Vaccines for Children Program.

What the New Schedule Would Look Like

The HHS assessment recommends reducing routine childhood vaccines from 17 to 11 diseases. Vaccines that would remain universally recommended include those for measles, mumps, rubella, pertussis (whooping cough), tetanus, diphtheria, Haemophilus influenzae type b (Hib), pneumonia, polio, human papillomavirus (HPV), and varicella (chickenpox), as CBS News reported.

Vaccines for flu, rotavirus, hepatitis A, hepatitis B, some forms of meningitis, and RSV would move to “shared clinical decision-making” or high-risk-only categories, meaning they would no longer be recommended for all children.

The administration points to data showing that in 1980, American children received 23 vaccine doses against 7 diseases. By 2024, that number had risen to at least 84 doses against 17 diseases — a figure the White House argues is out of step with peer nations. The HHS assessment found that the U.S. recommends more childhood vaccines than any peer nation, including more than twice as many doses as some European countries.

Legal Challenges and Institutional Turmoil

The executive order comes against a backdrop of significant legal and institutional conflict. In March 2026, Federal Judge Brian E. Murphy in Massachusetts temporarily blocked the administration from implementing the narrower schedule, ruling that Kennedy likely violated federal law when he fired all 17 members of the CDC’s ACIP and replaced them with appointees including multiple vaccine skeptics.

According to CBS News, Judge Murphy wrote that the government “disregarded” its traditional, scientifically grounded process for vaccine recommendations, and found that even under the most generous reading, only six of the new ACIP members appeared to have any meaningful experience in vaccines.

The American Academy of Pediatrics (AAP), which was a lead plaintiff in the lawsuit, broke significantly with the CDC by releasing its own childhood vaccine recommendations that align with the pre-2026 schedule. Dr. Andrew Racine, president of the AAP, said the ruling represented “a critical step to restoring scientific decision-making to federal vaccine policy.”

State-Level Resistance

States, not the federal government, hold the authority to require vaccinations for schoolchildren. And while CDC recommendations often influence state regulations, the administration’s shift has led to a fragmented response. According to AP News, health officials in 30 states have rejected at least some of the new CDC recommendations, and some states have begun creating their own alliances to counter the Trump administration’s guidance on vaccines.

Analysis and Implications

The executive order signals that the Trump administration is doubling down on its vaccine policy overhaul despite the March court ruling. By formally codifying the January HHS assessment as guiding federal policy, the administration appears to be attempting to establish a new legal basis for the narrower schedule as it appeals the Massachusetts decision.

The growing divergence between federal recommendations and state-level requirements creates a complex patchwork of vaccine policies across the country, potentially leaving parents and healthcare providers with conflicting guidance. Public health experts warn that if implemented, the narrower recommendations could lead to decreased vaccination rates for diseases like flu, hepatitis B, and RSV, potentially resulting in outbreaks of preventable illnesses.

Meanwhile, the restructuring of ACIP — a 62-year-old federal advisory committee — and the departure from the CDC’s traditional scientific processes have raised broader concerns about the politicization of public health institutions. Yale vaccine policy expert Jason Schwartz described the halting of an ACIP meeting for legal reasons as “unprecedented” in the committee’s history.

What to Watch For

The appeals court is expected to rule on the administration’s challenge to Judge Murphy’s injunction in the coming months. How the newly constituted ACIP conducts its review under the executive order, and whether Congress takes any legislative action regarding vaccine policy, will be critical factors shaping the future of childhood immunization in the United States. With the 2026 election cycle approaching, the political trajectory of this deeply divisive issue remains uncertain.